BioSpace News Archive

Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, announced positive topline results from its Phase III BRIDGE clinical trial of pegunigalsidase alfa, or PRX-102.

Cardinal Health reported financial results for the third quarter of fiscal 2020 ended March 31, 2020.Third quarter revenue was $39.2 billion, an increase of 11% from the third quarter of last year.

Eagle Pharmaceuticals, Inc. announced financial results for the three months ended March 31, 2020.

Codexis, Inc., a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare Conference on Monday, May 18 at 9:10 a.m. Eastern time.

Worldwide Ocaliva net sales of $72.7 million in the first quarter 2020, representing 40% growth over the prior year quarter

Passage Bio, Inc., a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, reported financial results for the first quarter ended March 31, 2020 and provided recent business highlights.

Nabriva Therapeutics plc announced that Ted Schroeder, Chief Executive Offer at Nabriva, will provide a company overview and business update at the BofA Securities 2020 Virtual Health Care Conference on Wednesday, May 13, at 11:00a.m.

Kamada Ltd., a plasma-derived biopharmaceutical company, announced that it will release financial results for the first quarter ended March 31, 2020, prior to the open of the U.S. financial markets on Monday, May 18, 2020.

IRADIMED CORPORATION, announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on previous claims pertaining to the wireless remote control of IV infusion pumps.

Strengthened balance sheet with $190 million in gross proceeds from a private placement in February 2020 and public equity offering in May 2020